Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Wormhole Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
Wormhole Capital

Wormhole Capital

Operating

NYC-based Wormhole Capital, the investment arm of Vivek Garipalli's family office, funds audacious, determined innovators.

Location
New York City, NY, US
Founded
2021
Firm
Compare
Portfolio
Employees
Website

Investments

GlossGenius
GlossGenius

Total Raised

$70.6M

Rounds

9

Series C$28MJuly 2023
Ossium Health
Ossium Health

Total Raised

$128.9M

Rounds

6

Series C$52MJuly 2023
Family First
Family First
Series A

Total Raised

$16.2M

Rounds

6

Series A$11MJuly 2023
Genetesis
Genetesis

Total Raised

$35.8M

Rounds

8

Series C$17.5MOctober 2022
Accordion
Accordion

Rounds

2

Secondary MarketSeptember 2022
Gravie
Gravie

Total Raised

$342.6M

Rounds

11

Series E$15MJune 2022
Wombat Exchange
Wombat Exchange

Total Raised

$5.3M

Rounds

3

Series UnknownApril 2022
Remedial Health
Remedial Health

Total Raised

$17.4M

Rounds

5

SeedMarch 2022
LexCheck
LexCheck
Series A

Total Raised

$25M

Rounds

4

Seed$5MMarch 2022
Placemakr
Placemakr

Total Raised

$192.1M

Rounds

6

Series Unknown$90MMarch 2022
Swiftly
Swiftly

Total Raised

$215.6M

Rounds

3

Series B$100MMarch 2022
Credo
Credo

Total Raised

$8.3M

Rounds

2

Seed$3MMarch 2022
Endless West
Endless West

Total Raised

$93.7M

Rounds

5

Series C$60MFebruary 2022
Medically Home
Medically Home

Total Raised

$274.5M

Rounds

5

Series Unknown$110MJanuary 2022
Curie.Bio
Curie.Bio

Rounds

2

SeedJanuary 2022
Uplift
Uplift

Total Raised

$18.7M

Rounds

3

Series Unknown$8MDecember 2021
Slope.io
Slope.io

Total Raised

$23M

Rounds

4

Series A$20MOctober 2021
Yendo
Yendo

Total Raised

$92.5M

Rounds

3

Seed$8.5MSeptember 2021
Misfits Market
Misfits Market

Total Raised

$526.5M

Rounds

5

Series C$225MSeptember 2021
Daloopa
Daloopa
Series C

Total Raised

$70.4M

Rounds

3

Series A$20MJuly 2021
Arrive Health
Arrive Health

Total Raised

$46.9M

Rounds

7

Undisclosed$8MJune 2021
Immuta
Immuta

Total Raised

$258.2M

Rounds

9

Series D$90MMay 2021
Carta
Carta

Total Raised

$1.2B

Rounds

13

Series UnknownApril 2021
Slice
Slice

Total Raised

$125M

Rounds

6

Series D$40MApril 2021
Reverie Labs
Reverie Labs
Series A

Total Raised

$25.1M

Rounds

3

Series A$25MFebruary 2021